|Conditional recommendation based on low-quality evidence; may consider switching to an IL-17i if the patient has severe psoriasis or contraindications to TNFi biologics, including congestive heart failure, previous serious infections, recurrent infections, or demyelinating disease.| |
|9. Switch to a TNFi biologic over an IL-12/23i biologic (PICO 52)|Low (72, 73, 76, 98, 100)|